Cloherty G - Search Results

1

Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon.

Huang DQ, Shen L, Phyo WW, Cloherty G, Butler EK, Kuhns MC, McNamara AL, Holzmayer V, Gersch J, Anderson M, Yang WL, Ngu JH, Chang J, Tan J, Ahmed T, Dan YY, Lee YM, Lee GH, Tan PS, Muthiah M, Khine HTW, Lee C, Tay A, Lim SG. Huang DQ, et al. Among authors: cloherty g. Antiviral Res. 2024 Apr 17;227:105876. doi: 10.1016/j.antiviral.2024.105876. Online ahead of print. Antiviral Res. 2024. PMID: 38641023

2

Sequence conservation of the region targeted by the Abbott RealTime HBV viral load assay in clinical specimens.

Cloherty GA, Rhoads J, Young TP, Parkin NT, Holzmayer V, Yuen L, Mullen C. Cloherty GA, et al. J Clin Microbiol. 2013 Apr;51(4):1260-2. doi: 10.1128/JCM.03003-12. Epub 2013 Jan 23. J Clin Microbiol. 2013. PMID: 23345287 Free PMC article.

3

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response.

Cloherty G, Chevaliez S, Sarrazin C, Herman C, Holzmayer V, Dawson G, Maasoumy B, Vermehren J, Wedemeyer H, Feld JJ, Pawlotsky JM. Cloherty G, et al. Sci Rep. 2016 Oct 20;6:35410. doi: 10.1038/srep35410. Sci Rep. 2016. PMID: 27762283 Free PMC article.

4

Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders.

Talal AH, Chen Y, Zeremski M, Zavala R, Sylvester C, Kuhns M, Brown LS, Markatou M, Cloherty GA. Talal AH, et al. J Subst Abuse Treat. 2017 Jul;78:37-42. doi: 10.1016/j.jsat.2017.04.011. Epub 2017 Apr 20. J Subst Abuse Treat. 2017. PMID: 28554601

5

Development and performance of prototype serologic and molecular tests for hepatitis delta infection.

Coller KE, Butler EK, Luk KC, Rodgers MA, Cassidy M, Gersch J, McNamara AL, Kuhns MC, Dawson GJ, Kaptue L, Bremer B, Wedemeyer H, Cloherty GA. Coller KE, et al. Sci Rep. 2018 Feb 1;8(1):2095. doi: 10.1038/s41598-018-20455-5. Sci Rep. 2018. PMID: 29391553 Free PMC article.

6

Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection.

Butler EK, Gersch J, McNamara A, Luk KC, Holzmayer V, de Medina M, Schiff E, Kuhns M, Cloherty GA. Butler EK, et al. Hepatology. 2018 Dec;68(6):2106-2117. doi: 10.1002/hep.30082. Epub 2018 Sep 22. Hepatology. 2018. PMID: 29734472

7

High prevalence of hepatitis delta virus in Cameroon.

Butler EK, Rodgers MA, Coller KE, Barnaby D, Krilich E, Olivo A, Cassidy M, Mbanya D, Kaptue L, Ndembi N, Cloherty G. Butler EK, et al. Among authors: cloherty g. Sci Rep. 2018 Aug 2;8(1):11617. doi: 10.1038/s41598-018-30078-5. Sci Rep. 2018. PMID: 30072752 Free PMC article. Clinical Trial.

8

Identification of hepatitis B virus genotype I in Thailand.

Holzmayer V, Hance R, Defechereux P, Grant R, Kuhns MC, Cloherty G, Rodgers MA. Holzmayer V, et al. Among authors: cloherty g. J Med Virol. 2019 Apr;91(4):717-721. doi: 10.1002/jmv.25346. Epub 2018 Nov 8. J Med Virol. 2019. PMID: 30351478 Free PMC article.

9

Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.

Kuhns MC, McNamara AL, Holzmayer V, Cloherty GA. Kuhns MC, et al. Virol J. 2019 Apr 3;16(1):43. doi: 10.1186/s12985-019-1154-4. Virol J. 2019. PMID: 30943997 Free PMC article.

10

Serum Hepatitis B Virus RNA as a Potential Diagnostic Biomarker During Chronic Hepatitis B Virus Infection.

Cloherty G, Butler E, Kuhns M. Cloherty G, et al. Clin Liver Dis (Hoboken). 2019 Mar 29;13(3):90-92. doi: 10.1002/cld.774. eCollection 2019 Mar. Clin Liver Dis (Hoboken). 2019. PMID: 30988945 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page